Sundar.M
☆    

India,
2018-09-27 13:11
(2009 d 07:10 ago)

Posting: # 19330
Views: 3,351
 

 RSABE - Sequence [RSABE / ABEL]

Dear all,

What would be the advantages/disadvantages of following 6 sequences (TRR, RTR, RRT, RTT, TRT and TTR) in a RSABE design, instead of 3 sequences as per FDA recommendations. Your comments are highly appreciated.


Thanks
Sundar. M
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2018-09-28 15:15
(2008 d 05:06 ago)

@ Sundar.M
Posting: # 19337
Views: 2,821
 

 Suggested: TRT|RTR

Hi Sundar,

❝ […] advantages/disadvantages of following 6 sequences (TRR, RTR, RRT, RTT, TRT and TTR) in a RSABE design, instead of 3 sequences as per FDA recommendations.


Advantages
  • Additionally to the estimate of CVwR you get the one of CVwT (good to know esp. if your study is a pilot and you want to design a pivotal study where CVwR ≠ CVwT). In the partial replicate you have to assume that CVwR = CVwT.
  • If swR <0.294 (only ABE acceptable) no convergence issues in the mixed-effects model with the FDA’s covariance-specification.
Disadvantages
  • Sample size is a multiple of six (instead of three in the partial replicate and two in the three-period full replicate).
  • Design currently not implemented in PowerTOST’s function sampleN.RSABE().
If you want to kill two birds with one stone I recommend the three-period two-sequence full replicate design (TRT | RTR) instead.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Sundar.M
☆    

India,
2018-09-28 15:36
(2008 d 04:45 ago)

@ Helmut
Posting: # 19338
Views: 2,642
 

 Suggested: TRT|RTR

Thank you HS!
UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
86 visitors (0 registered, 86 guests [including 6 identified bots]).
Forum time: 19:21 CET (Europe/Vienna)

Nothing shows a lack of mathematical education more
than an overly precise calculation.    Carl Friedrich Gauß

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5